When fat goes, what else goes with it?

We are in the midst of what may be the most significant shift in weight management medicine in a generation.

Millions of people are losing meaningful amounts of weight — 30, 40, 50 pounds — in timeframes that were not previously possible outside of bariatric surgery. A1C is dropping. Blood pressure is improving. The metrics look genuinely good.

I am not here to undermine that. For many people, these medications are life-changing.

But here is the question that is not being asked: when 40 pounds of adipose tissue disappears — and disappears relatively quickly — what was stored in it? And where does that go?

This is not a new question. It is a newly urgent one.

Supporting biotransformation (aka detox) pathways has been a cornerstone of my practice since day one — long before GLP-1 medications became a household term.

Why? Because any program that facilitates meaningful weight loss has always needed to account for this. When fat breaks down, what was stored in it enters circulation — and the body needs adequate support to handle what gets released.

What has changed is the volume, the speed, and the sheer number of people now losing weight who are not being asked this question at all.

Fat is not just stored energy

Adipose tissue — body fat — is one of the body's primary long-term storage depots for a class of compounds called lipophilic environmental pollutants.

Lipophilic means fat-soluble. These compounds do not dissolve in water. The body cannot readily excrete them. So it does the only thing it can — it tucks them away in fat tissue, where they can sit, relatively contained, for years or even decades.

We are talking about organochlorine pesticides. PCBs. Dioxins. Flame retardants. Heavy metals.

Collectively, many of these fall under the category of persistent organic pollutants — POPs — and xenobiotics: foreign compounds the body was never designed to metabolize efficiently. Persistent, because they do not break down easily. Pollutants, because that is precisely what they are.

We all have them. We have accumulated them over a lifetime — through food, through air, through water, through the low-level environmental contact that modern life makes essentially unavoidable. 

For as long as weight stayed stable, much of that burden stayed relatively contained.

But weight loss — or any hypo-caloric state — changes the equation.

This is not speculation...

Studies in every mammalian species examined — including humans — show the same finding: when the body is burning fat, whether from fasting, caloric restriction, or significant weight loss, stored toxins are released into the bloodstream.[1,2]

The fat breaks down. The compounds stored within it do not disappear. They enter the bloodstream.

A landmark study in the International Journal of Obesity found that weight loss was associated with significant increases in plasma concentrations of several organochlorine compounds — and that the more substantial and rapid the weight loss, the more pronounced the effect.[3]

There is a further metabolic consequence that receives even less attention: the mobilization of these compounds has been associated with a measurable decrease in resting metabolic rate — independent of the expected drop from reduced body mass alone.[4] In other words, the release of stored toxins during fat loss may itself suppress metabolism, which works directly against the outcomes being pursued.

And here is the part that makes this especially relevant right now: the faster and more sustained the weight loss — exactly what GLP-1 medications are designed to produce — the more significant the mobilization. The release is real. The blood-level increase is documented.

Small does not mean insignificant...

When people hear that the amounts of these compounds circulating in the blood are small, the temptation is to dismiss them.

Don't.

Think about how estrogen is measured in the body: in picograms per milliliter. A picogram is one trillionth of a gram. And yet estrogen, at those vanishingly small concentrations, orchestrates bone density, cardiovascular function, mood, reproductive health, and metabolic signaling throughout the body. Tiny amounts. Profound effects.

Many of the compounds mobilized during fat loss — particularly those with endocrine-disrupting properties — operate on similar principles. They do not need to be present in large quantities to interfere with thyroid signaling, estrogen metabolism, insulin sensitivity, or mitochondrial function. Potency is not proportional to concentration. 

Water-soluble vs fat-soluble: why this matters so much

Here is a distinction that clarifies everything:

If a compound is water-soluble, the body has ready-made exit routes. We urinate it out. We sweat it out. We excrete it in stool. We even release small amounts through saliva and tears. Water-soluble waste is something the body handles efficiently and continuously.

Fat-soluble compounds are an entirely different challenge. They require the liver to convert them — via the two-phase biotransformation process — into water-soluble forms that can then be excreted. Without that transformation, they either remain stored, recirculate, or redistribute to other lipid-rich tissues: the brain, the myelin sheaths of nerves, adipose tissue elsewhere in the body.

This is not a minor technical detail. It is the entire reason why supporting detoxification pathways is non-negotiable during weight loss — not a nice-to-have, not a wellness trend, but a biological requirement.

Detox is a nutrient-dependent process

I have written about this in detail before — Doing a detox? Avoid these classic mistakes — and the principles are worth revisiting here in the context of GLP-1 weight loss.

In functional medicine, we call detoxification what it actually is: biotransformation. The liver does not simply "flush out" toxins. It runs a two-phase biochemical operation.

• Phase I — the activation phase — uses enzymes (primarily the cytochrome P450 family) to begin breaking down fat-soluble compounds. Think of it as the liver gathering up the mess and getting it into bags. The important catch: Phase I can generate reactive intermediates — potentially more chemically active than the original compound — if Phase II is not ready to receive them.
• Phase II — the conjugation phase — attaches molecules to those intermediates (amino acids like glycine, taurine, and glutamine; cofactors including B2, B3, B6, B12, and folate; sulfate and glucuronic acid) that neutralize them and make them water-soluble enough to excrete. This is where the bags get carried out of the house.

If the nutrient requirements for Phase II are running low — which is extremely common in people who have been in caloric restriction, who have poor protein intake, or who were nutritionally depleted before they started losing weight — Phase I keeps generating reactive intermediates that Phase II cannot neutralize. The cleanup is happening. The garbage is just piling up in the hallway.

This is precisely why a basic juice cleanse, or any purely food-restriction based approach to detox, can often make people feel worse.

One of the most common things people say after an over-the-counter or random cleanse is "I felt awful — it must have been working really well."

In reality, feeling awful during a detox is usually a sign that it is not working — that Phase I has been activated, reactive intermediates are building up, and Phase II does not have the raw materials to complete the job. Feeling temporarily worse is not a badge of honor. It can be a signal that the process needs better support.

After all — we are what we eat, drink, breathe, touch, and can't eliminate.

The most overlooked issue in detox: The exit route

Here is where we reach the single most common oversight in the entire detox space, and it applies with full force to anyone losing weight rapidly on a GLP-1.

You cannot meaningfully detox someone who is constipated.

Read that again.

Bile is the liver's primary vehicle for excreting the fat-soluble compounds that have been processed through Phase I and Phase II. Bile carries those neutralized compounds into the small intestine, where they bind to fiber and are carried out of the body in stool.

But if stool transit is slow — if bowels are moving once every two or three days, or incompletely — those compounds do not make a clean exit. They sit in the intestine long enough for certain bacterial enzymes (notably beta-glucuronidase, produced by dysbiotic organisms) to unbind them from their conjugates and reabsorb them back into circulation. The liver did its job. The gut did not complete the handoff.

In functional medicine, we sometimes refer to this as Phase III of biotransformation — the elimination phase. And without it, Phases I and II are partially futile.

This matters particularly for anyone on a GLP-1 medication, since slowed gut motility is a known side effect of the drug itself. If the exit route is blocked while stored pollutants are being mobilized from dissolving fat tissue, those compounds have nowhere to go. They recirculate. They redistribute. And the symptoms that result are unlikely to be attributed to the right cause.

One more prerequisite that rarely gets mentioned: bile flow itself must be assessed before initiating any detox protocol. If bile flow is already compromised — due to gallbladder dysfunction, liver congestion, or subclinical cholestasis — the excretion pathway is operating with a blocked drain regardless of how well Phases I and II are supported. Signs worth noting include light or clay-colored stools, intolerance to fatty foods, upper right quadrant discomfort, and generalized itching. These warrant assessment before ramping up any detox support.

Before anything else: the exit route has to be open. This is not optional. It is foundational.

Listen to your body...

Fatigue, brain fog, joint aches, mood changes — these are commonly attributed to the medication itself. And sometimes that is accurate. But they are also consistent with a body managing a significant toxic load from compounds now circulating at higher levels than before the weight loss began.[5,6]

Do not dismiss these symptoms. They are not background noise. They are signals — and the right question is not only "is this a side effect?" but "what is my body currently managing, and what does it need?"

What a more complete approach looks like

For anyone currently on a GLP-1 medication, or supporting someone who is, here is the kind of framework that has been central to my practice long before these medications existed:

The exit route has to be open before anything else. This means regular, complete bowel movements — at least once daily — good bile flow, and a healthy gut microbiome. All three are part of the same Phase III elimination process. Bile carries processed toxins into the intestine; fiber and a well-functioning microbiome bind them and carry them out. If any part of this is sluggish or compromised, compounds recirculate rather than leave. Nothing else works without this foundation.

Symptoms during active loss are data, not background noise. Fatigue, brain fog, joint discomfort, and mood changes belong in the clinical picture, not the "probably just the medication" category.

Pacing matters where possible. More gradual weight loss gives the body more time to manage what is being released. Not always possible — but always worth considering.

In summary

Weight loss is not just a subtraction. It is a biochemical event — and what gets released when fat breaks down matters as much as how much fat is lost.

The question of what was stored in that fat, and what the body needs to handle its release, should be part of every weight loss conversation. 

Because anyone losing 40 pounds and feeling worse than expected deserves a better answer than "that's probably just the Ozempic."

It might be. But it might also be 40 pounds of stored history, finally moving — and a body that needs the right support to handle the traffic.

Listen to your body. The messages are there for a reason.

TL;DR

• Fat stores more than energy. Adipose tissue accumulates fat-soluble pollutants and foreign compounds over a lifetime. When fat breaks down, they enter circulation.
• Every mammalian study confirms it. Xenobiotic levels in the blood rise during fat loss — in every species studied, including humans. The more rapid the loss, the greater the release.
• Small doses, big effects. Estrogen is measured in picograms — trillionths of a gram — yet it runs your entire hormonal system. Many of these compounds operate the same way. 
• Water-soluble = easy out. Fat-soluble = you need a plan. Water-soluble compounds leave via urine, sweat, stool, saliva, and tears. Fat-soluble ones require the liver to convert them first — which takes specific nutrients, protein, and a working digestive system.
• The gut has to be working before you detox. Constipation is a dealbreaker. Without regular bowel movements and good bile flow, processed toxins get reabsorbed rather than eliminated.
• "Feeling awful" during weight loss deserves further evaluation. Fatigue, brain fog, joint pain, and mood changes may not be the medication. They may be your body asking for support.
• Every weight loss program must include detox support. This was true long before GLP-1 medications. The biology has not changed.
• Remember, you are what we eat, drink, breathe, touch — and can't eliminate!
   

References

[1] Tremblay, A., et al. (2004). Thermogenesis and weight loss in obese individuals: a primary association with organochlorine pollution. International Journal of Obesity.

[2] Chevrier, J., et al. (2000). Body weight loss increases plasma and adipose tissue concentrations of potentially toxic pollutants in obese individuals. International Journal of Obesity.

[3] Pelletier, C., et al. (2002). Associations between weight loss-induced changes in plasma organochlorine concentrations, serum T3 concentration, and resting metabolic rate. Toxicological Sciences.

[4] Tremblay, A. & Chaput, J.P. (2009). Adaptive thermogenesis can make a difference in the ability of obese individuals to lose body weight. International Journal of Obesity. (On metabolic rate suppression associated with organochlorine mobilization during weight loss.)

[5] Lee, D.H., et al. (2007). Association between serum concentrations of persistent organic pollutants and insulin resistance among nondiabetic adults. Diabetes Care.

[6] Carpenter, D.O. (2006). Polychlorinated biphenyls (PCBs): routes of exposure and effects on human health. Reviews on Environmental Health.

[7] Hodges, R.E. & Minich, D.M. (2015). Modulation of metabolic detoxification pathways using foods and food-derived components. Journal of Nutrition and Metabolism.

[8] Liska, D.J. (1998). The detoxification enzyme systems. Alternative Medicine Review.